Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    "Ocular cicatricial pemphigoid"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid
Condition: Ocular Cicatricial Pemphigoid
Intervention: Drug: Rituximab
2 Recruiting Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Conditions: Chemical Injuries;   Unspecified Complication of Corneal Transplant;   Autoimmune Diseases;   Ocular Cicatricial Pemphigoid;   Stevens Johnson Syndrome;   Lupus Erythematosus, Systemic;   Rheumatoid Arthritis;   Other Autoimmune Diseases
Intervention: Drug: Riboflavin

Indicates status has not been verified in more than two years